Literatur
Dachs TM, Duca F, Rettl R, Binder-Rodriguez C, Dalos D, Camuz Ligios L, Kammerlander A Grünig E, Pretsch I, Steringer-Mascherbauer R, Ablasser K, Wargenau M, Mascherbauer J, Lang IM, Hengstenberg C, Badr-Eslam R, Kastner J, Bonderman D. Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial. Eur Heart J. 2022; https://doi.org/10.1093/eurheartj/ehac389.
Eslam BR, Öztürk B, Rettl R, Capelle C, Qin H, Binder C, Dachs TM, Camuz Ligios L, Duca F, Dalos D, Schrutka L, Alasti F, Kastner J, Vila G, Bonderman D. Impact of tafamidis and optimal background treatment on physical performance in patients with transthyretin amyloid cardiomyopathy. Circulation. 2022; https://doi.org/10.1161/CIRCHEARTFAILURE.121.008381.
Schrutka L, Seirer B, Rettl R, Dachs TM, Binder-Rodriguez C, Duca F, Dalos D, Badr-Eslam R, Kastner J, Hengstenberg C, Frommlet F, Bonderman D. Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death. Cardiovasc Med. 2022; https://doi.org/10.3389/fcvm.2022.921132.
Hauck SR, Kern M, Dachs TM, Haider L, Stelzmüller ME, Ehrlich M, Loewe C, Funovics MA. Applicability of endovascular branched and fenestrated aortic arch repair devices to treat residual type A dissection after ascending replacement. J Vasc Surg. 2022; https://doi.org/10.1016/j.jvs.2022.08.018.
Dachs TM, Hauck SR, Kern M, Klausenitz C, Funovics M. Fenestrierte und verzweigte endovaskuläre Aortenprothesen – ein Update. Radiologe. 2022; https://doi.org/10.1007/s00117-022-01019-1.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
MUW researcher of the month. Wien Klin Wochenschr 135, 660–661 (2023). https://doi.org/10.1007/s00508-023-02305-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-023-02305-1